(Q33401326)

26 July 2017

title

Novel adverse events of bevacizumab in the US FDA adverse event reporting system database: a disproportionality analysis (English)

1 reference

26 July 2017

1 reference

Behrooz K Shamloo

1

1 reference

26 July 2017

Pankdeep Chhabra

2

1 reference

26 July 2017

Andrew N Freedman

3

1 reference

26 July 2017

Arnold Potosky

4

1 reference

26 July 2017

Jennifer Malin

5

1 reference

26 July 2017

Sheila Weiss Smith

6

1 reference

26 July 2017

publication date

1 June 2012

1 reference

26 July 2017

1 reference

26 July 2017

volume

35

1 reference

26 July 2017

issue

6

1 reference

26 July 2017

page(s)

507-518

1 reference

https://scigraph.springernature.com/pub.10.2165/11597600-000000000-00000

26 July 2017

exact match

0 references

cites work

The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide

1 reference

https://api.crossref.org/works/10.2165%2F11597600-000000000-00000

Surveillance for potential adverse events associated with the use of intravitreal bevacizumab for retinal and choroidal vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597600-000000000-00000

Bevacizumab immune complexes activate platelets and induce thrombosis in FCGR2A transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597600-000000000-00000

Fournier's gangrene as a possible side effect of bevacizumab therapy for resected colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597600-000000000-00000

Interstitial lung disease during chemotherapy combined with oxaliplatin and/or bevacizumab in advanced colorectal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597600-000000000-00000

Regulation of VEGF/VPF expression in tumor cells: consequences for tumor growth and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597600-000000000-00000

Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597600-000000000-00000

Retrospective exploratory analysis of VEGF polymorphisms in the prediction of benefit from first-line FOLFIRI plus bevacizumab in metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597600-000000000-00000

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597600-000000000-00000

Nitric oxide production and regulation of endothelial nitric-oxide synthase phosphorylation by prolonged treatment with troglitazone: evidence for involvement of peroxisome proliferator-activated receptor (PPAR) gamma-dependent and PPARgamma-indepen

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597600-000000000-00000

Apical ballooning syndrome during treatment with a vascular endothelial growth factor receptor antagonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597600-000000000-00000

Nitric oxide synthase modulates angiogenesis in response to tissue ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597600-000000000-00000

Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597600-000000000-00000

Vascular endothelial growth factor governs endothelial nitric-oxide synthase expression via a KDR/Flk-1 receptor and a protein kinase C signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597600-000000000-00000

Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597600-000000000-00000

Nitric oxide and cardiac function

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597600-000000000-00000

Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597600-000000000-00000

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597600-000000000-00000

Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597600-000000000-00000

Extent of vascularization as a prognostic indicator in thin (< 0.76 mm) malignant melanomas

21 January 2018

1 reference

12 December 2020

Vascular endothelial growth factor and liver regeneration

1 reference

12 December 2020

Blood pressure control, risk factors and cardiovascular prognosis in patients with diabetes: 30 years of progress

1 reference

12 December 2020

Increased susceptibility to development of triggered activity in myocytes from mice with targeted disruption of endothelial nitric oxide synthase

1 reference

12 December 2020

Microcirculation in hypertension: a new target for treatment?

1 reference

12 December 2020

Vascular endothelial growth factor delays onset of failure in pressure-overload hypertrophy through matrix metalloproteinase activation and angiogenesis

1 reference

12 December 2020

Vascular endothelial growth factor secreted by replicating hepatocytes induces sinusoidal endothelial cell proliferation during regeneration after partial hepatectomy in rats

1 reference

12 December 2020

Retinal pigment epithelial tears after intravitreal bevacizumab injection for exudative age-related macular degeneration

1 reference

12 December 2020

Aortic dissection in young patients with chronic hypertension

1 reference

12 December 2020

10.2165/11597600-000000000-00000

Identifiers

DOI

1 reference

Dimensions Publication ID

26 July 2017

1011817877

0 references

1 reference